Endometriosis: cost estimates and methodological perspective
1 Research Centre for Pharmaceutical Care and Pharmaco-economics, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Onderwijs en Navorsing 2, PO Box 521, Herestraat 49, 3000 Leuven, Belgium 2 Endometriosis.org, London, UK 3 Leuven University Fertility Center, University Hospitals Leuven, 3000 Leuven, Belgium
4 Correspondence address. Tel: +32-16-323465; Fax: +32-16-323468; E-mail: steven.simoens{at}pharm.kuleuven.be
This article aims to provide a systematic review of estimates and methodology of studies quantifying the costs of endometriosis. Included studies were cost-of-illness analyses quantifying the economic impact of endometriosis and cost analyses calculating diagnostic and treatment costs of endometriosis. Annual healthcare costs and costs of productivity loss associated with endometriosis have been estimated at $2801 and $1023 per patient, respectively. Extrapolating these findings to the US population, this study calculated that annual costs of endometriosis attained $22 billion in 2002 assuming a 10% prevalence rate among women of reproductive age. These costs are considerably higher than those related to Crohn's disease or to migraine. To date, it is not possible to determine whether a medical approach is less expensive than a surgical approach to treating endometriosis in patients presenting with chronic pelvic pain. Evidence of endometriosis costs in infertile patients is largely lacking. Cost estimates were biased due to the absence of a control group of patients without endometriosis, inadequate consideration of endometriosis recurrence and restricted scope of costs. There is a need for more and better-designed studies that carry out longitudinal analyses of patients until the cessation of their symptoms or that model the chronic nature of endometriosis.
Key words: cost estimates / endometriosis / GnRH agonists / laparoscopy
Received on December 7, 2006; revised March 2, 2007; accepted on March 29, 2007
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Kvaskoff, S. Mesrine, F. Clavel-Chapelon, and M.-C. Boutron-Ruault Endometriosis risk in relation to naevi, freckles and skin sensitivity to sun exposure: the French E3N cohort Int. J. Epidemiol., August 1, 2009; 38(4): 1143 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A Missmer Commentary: Endometriosis--epidemiologic considerations for a potentially 'high-risk' population Int. J. Epidemiol., August 1, 2009; 38(4): 1154 - 1155. [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Bruner-Tran, K. G. Osteen, and A. J. Duleba Simvastatin Protects against the Development of Endometriosis in a Nude Mouse Model J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2489 - 2494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-W. Guo Recurrence of endometriosis and its control Hum. Reprod. Update, July 1, 2009; 15(4): 441 - 461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Diamanti-Kandarakis, J.-P. Bourguignon, L. C. Giudice, R. Hauser, G. S. Prins, A. M. Soto, R. T. Zoeller, and A. C. Gore Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement Endocr. Rev., June 1, 2009; 30(4): 293 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-W. Guo, L. Hummelshoj, D. L. Olive, S. E. Bulun, T. M. D'Hooghe, and J. L.H. Evers A call for more transparency of registered clinical trials on endometriosis Hum. Reprod., June 1, 2009; 24(6): 1247 - 1254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Gargett, K. E. Schwab, R. M. Zillwood, H. P.T. Nguyen, and D. Wu Isolation and Culture of Epithelial Progenitors and Mesenchymal Stem Cells from Human Endometrium Biol Reprod, June 1, 2009; 80(6): 1136 - 1145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. W. Rogers, T. M. D'Hooghe, A. Fazleabas, C. E. Gargett, L. C. Giudice, G. W. Montgomery, L. Rombauts, L. A. Salamonsen, and K. T. Zondervan Priorities for Endometriosis Research: Recommendations From an International Consensus Workshop Reproductive Sciences, April 1, 2009; 16(4): 335 - 346. [Abstract] [PDF]
|
|
|
|
|
|
P. Vercellini, P.G. Crosignani, A. Abbiati, E. Somigliana, P. Vigano, and L. Fedele The effect of surgery for symptomatic endometriosis: the other side of the story Hum. Reprod. Update, March 1, 2009; 15(2): 177 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Aghajanova, A. Hamilton, J. Kwintkiewicz, K.C. Vo, and L.C. Giudice Steroidogenic Enzyme and Key Decidualization Marker Dysregulation in Endometrial Stromal Cells from Women with Versus Without Endometriosis Biol Reprod, January 1, 2009; 80(1): 105 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Olive Gonadotropin-Releasing Hormone Agonists for Endometriosis N. Engl. J. Med., September 11, 2008; 359(11): 1136 - 1142. [Full Text] [PDF]
|
|
|
|
|
|
G. W. Montgomery, D. R. Nyholt, Z. Z. Zhao, S. A. Treloar, J. N. Painter, S. A. Missmer, S. H. Kennedy, and K. T. Zondervan The search for genes contributing to endometriosis risk Hum. Reprod. Update, September 1, 2008; 14(5): 447 - 457. [Abstract] [Full Text] [PDF]
|
|